Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
Infectious Disease·MeSH: COVID-19
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| remestemcel-l | Mesoblast Limited (MESO) |
Unknown(1)
| Drug | Company |
|---|---|
| diphenhydramine | Mesoblast Limited (MESO) |
Compare drugs
Frequently asked questions
How many drugs are in development for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)?
BioSniper tracks 2 drugs in development for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) across 1 company.
How many clinical trials target Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)?
There are 1 clinical trial targeting Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) tracked by BioSniper.
Deep-dive into Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis